LIN

Business Context and Reporting Period

Company: Linde PLC
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and nine months ended September 30, 2024
Business Overview: Linde is a global leader in industrial gases and engineering, serving healthcare, chemicals, energy, manufacturing, and electronics sectors. The company operates through four reportable segments: Americas, EMEA, APAC, and Engineering.

Key Financial Metrics

Material Changes vs. Prior Period

• Sales Growth: Q3 2024 sales increased 2% year-over-year, driven by a 2% price increase. Volumes were flat, with base declines offset by new project start-ups. Currency translation negatively impacted sales by 1% due to the weakening Brazilian real and Mexican peso.
• Profitability: Reported operating profit rose 2% in Q3. However, Adjusted Operating Profit (excluding cost reduction charges and purchase accounting impacts) increased 7% to $2,477 million, reflecting strong pricing and productivity gains.
• Cost Reduction Charges: A significant one-time charge of $145 million was recorded in Q3 2024 (vs. $2 million in Q3 2023) related to a cost reduction program, primarily severance costs.
• Segment Performance:
  • Engineering: Sales surged 31% in Q3 due to project timing, though operating profit declined 7% due to the prior year's benefit from the wind-down of sanctioned Russian projects.
  • EMEA: Operating profit grew 11% driven by pricing and productivity.
  • APAC: Sales grew 5% with volume increases in the electronics market.
• Debt & Liquidity: Total debt increased to $22.3 billion from $19.4 billion at year-end 2023, driven by new issuances to refinance maturing notes. Cash and cash equivalents increased to $5.2 billion.

Guidance, Outlook, and Risks

• Outlook: Management provides quarterly updates via earnings releases and investor calls but does not provide specific numerical guidance in this filing. The company expects continued growth driven by pricing and productivity, partially offset by cost inflation and currency headwinds.
• Capital Allocation:
  • Dividends: Quarterly dividend increased 9% to $1.39 per share.
  • Share Repurchases: $1.7 billion repurchased under the $15 billion program in 2024; $13.3 billion remains authorized.
  • CapEx: Capital expenditures for the first nine months were $3.2 billion, up $611 million year-over-year, driven by new plant investments for backlog growth.
• Risks and Contingencies:
  • Russia Sanctions: Ongoing legal disputes with RusChemAlliance (RCA) regarding terminated engineering projects. A $1.2 billion contingent liability is recorded. While Linde secured favorable rulings in Hong Kong, Russian courts have ruled in favor of RCA, and enforcement proceedings are pending.
  • Legal Proceedings: Ongoing tax disputes in Brazil (Refis Program) and appraisal proceedings in Germany regarding the 2018 merger squeeze-out.
  • Market Risks: Exposure to foreign currency fluctuations, interest rate changes, and energy/commodity costs.

Investor Verification Checklist

• Adjusted vs. Reported Metrics: Verify the impact of the $145 million cost reduction charge and $246 million purchase accounting impact on Q3 operating profit to understand core operational performance.
• Russia Exposure: Monitor the status of the $1.2 billion contingent liability and the enforcement of Russian court rulings against Linde's assets.
• Currency Impact: Assess the sensitivity of future earnings to the Brazilian real and Mexican peso, which negatively impacted Q3 sales.
• Engineering Backlog: Review the $7.0 billion sale of gas backlog for large projects under construction to gauge future revenue visibility.
• Debt Maturity Profile: Confirm the company's ability to manage debt refinancing given the increase in total debt and higher interest rates.